Introduction

Prediabetes is a high-risk state for diabetes affecting approximately 470 million people worldwide. However, it is unclear whether all of its subcategories (isolated impaired fasting glucose [iIFG], isolated impaired glucose tolerance [iIGT], and their combination [IFG+IGT]) share the same pathophysiological background with diabetes. The progression rates of prediabetic conditions to diabetes are strikingly different [1].

A positive family history of type 2 diabetes (FHD) nearly doubles the risk of diabetes in the offspring [2]. As FHD is associated with all characteristic features of diabetes pathophysiology, it may well be that individuals with FHD are at increased risk of prediabetes.

In this study, we performed a meta-analysis from four German studies comprising 8,106 non-diabetic individuals seeking answers for the question whether FHD is associated with prediabetes and whether its subcategories behave differently. We furthermore tested whether these associations are modified by variables such as sex, age and obesity.

Methods

Participants

Data from four pre-existing cohort studies conducted by partner institutes of the German Center for Diabetes Research (Deutsches Zentrum für Diabetesforschung [DZD]) were used in this meta-analysis. The analysis comprised individuals without previously diagnosed diabetes who underwent 75 g OGTTs in the morning, after at least 10 h fasting. Individuals with incidental diabetes (fasting glucose ≥7.0 or 2 h glucose ≥11.1 mmol/l) were excluded. Prediabetes was taken as including IFG and/or IGT, defined according to the recommendations of the ADA [3].

Background information on each study population is provided in electronic supplementary material (ESM) Table 1.

The investigations were performed in accordance with the Declaration of Helsinki, and all studies were approved by local ethics committees. All participants provided written informed consent.

Characteristics of the participants for each study are shown in Table 1, with glucose tolerance data provided in ESM Table 2.

Table 1 Characteristics of the participants of the four study populations

Definition of FHD

For this meta-analysis, FHD was uniformly defined as at least one first degree relative with type 2 diabetes. Participants were asked about first degree relatives with type 2 diabetes (parents, siblings or children) using questionnaires or personal interviews. The questionnaire in the Cooperative Research in the Region of Augsburg (KORA) study comprised only parents and siblings.

Statistical analyses

Data are given as means ± SD. Means were compared with t tests and the Wilcoxon test, as appropriate. Binary outcomes were tested using Fisher’s exact test. Multivariable logistic regression models were used to analyse associations between FHD and prediabetes. Prediabetes categories were applied as dichotomous outcomes (prediabetes vs normal glucose tolerance [NGT], iIFG vs NGT, iIGT vs NGT, IFG+IGT vs NGT). Covariates with non-normal distribution were log e -transformed to approximate normal distribution in the models. ORs and their 95% CIs have been calculated separately in each centre. Age and BMI were dichotomised for interaction tests. For age, a cut-off of 45 years, a numeral close to both the weighted average of the four study populations and the median age in Germany, was used. For BMI, we applied the clinical cut-off for obesity (30 kg/m2).

Calculations were carried out using JMP 8.0 (SAS Institute, Cary, NC, USA) in TUEF (Tübingen Family Study), SAS 9.2 (SAS Institute), in KORA, and IBM SPSS Statistics 18 and 19 (IBM, Ehningen, Germany) in PRAEDIAS (Prävention des Diabetes – Selbst aktiv werden [Active in Diabetes Prevention]) and MeSyBePo (Metabolic Syndrome Berlin Potsdam).

Logistic regression results from all centres were pooled with MIX 2.0 Pro (Version 2.0.1.4, www.biostatxl.com). Fixed-effects models were used throughout the study. Weighting was performed with the Mantel–Haenszel method. Heterogeneity was low (p for Cochrane’s Q >0.05) for all analysed outcome variables, except for iIGT (Q = 12.6, p = 0.006).

Results

FHD was significantly associated with the risk of prediabetes in each single study as well as the meta-analysis (OR 1.40; 95% CI 1.27, 1.54, p < 0.001), see Fig. 1a–d. This association remained significant in the multivariable logistic regression model adjusting for the covariables sex, age and BMI (OR 1.26; 95% CI 1.14, 1.40, p ≤ 0.001). When stratifying for prediabetes subcategories, the association with FHD was established for iIFG (OR 1.37; 95% CI 1.20, 1.57, p < 0.001), iIGT (OR 1.25; 95% CI 1.07, 1.46, p < 0.001) and IFG+IGT (OR 1.64; 95% CI 1.40, 1.93, p < 0.001) in meta-analyses. While the association remained significant in iIFG (OR 1.26; 95% CI 1.09, 1.45, p < 0.001) and IFG+IGT (OR 1.47; 95% CI 1.23, 1.76, p < 0.001) after adjusting for sex, age and BMI, the association of FHD with iIGT was no longer significant after adjustment for these confounders (OR 1.11; 95% CI 0.94, 1.3, p = 0.21).

Fig. 1
figure 1

Association of a positive family history of diabetes with prediabetes (a), isolated IFG (b), isolated IGT (c) and combined IFG+IGT (d)

We further tested the interaction of FHD with sex, age and obesity in all centres for different prediabetes subcategories (see ESM Table 3). Interaction or a trend for interaction (p < 0.10) with consistent effect direction was observed between FHD and BMI for the determination of prediabetes in two out of four studies. In a subsequent meta-analysis of BMI-stratified subpopulations, the association of FHD with prediabetes was seen only in the non-obese subpopulations, but not in the obese subpopulations (see ESM Figure 1).

Discussion

In the present analysis of 8,106 individuals characterised by OGTT in four DZD centres, we found that FHD is associated with a 40% increased risk of having prediabetes. When taking additional risk factors such as obesity and age in a multivariable model into account, the strength of the association was attenuated to 26%.

An earlier study from Sweden also found a 50% increased risk of prediabetes in participants with FHD [4]. In our meta-analysis, the OR was lowest for iIGT (1.25) compared with iIFG (1.37) and IFG+IGT (1.64). Given that IGT implies a higher conversion rate to diabetes than IFG [1], its weaker association with FHD was surprising. As IFG is predominantly associated with hepatic insulin resistance while IGT is often associated with muscle insulin resistance [5] as well as impaired insulin secretion, one may speculate that FHD might have a stronger link to hepatic insulin resistance. Of note, the lower OR of iIGT is particularly striking in the PRAEDIAS and MeSyBePo studies, and the relatively large inter-centre differences lead to an increased heterogeneity for this variable in the meta-analysis.

An analysis of the Nurses’ Health Study showed that BMI accounted for 21% of the association between FHD and diabetes in women [6]. In the European Prospective Investigation into Cancer and Nutrition (EPIC)–InterAct study, however, lifestyle, anthropometric and genetic risk factors did not sufficiently explain the excess risk associated with FHD [7]. Our data suggest that FHD is associated with prediabetes in non-obese rather than in obese individuals. This might indicate that the effect of FHD on prediabetes becomes readily measurable only when not overshadowed by strong risk factors such as obesity. Most diabetes risk questionnaires, including the German Diabetes Risk Score [8] and the Finnish Findrisk [9], heavily rely on markers of obesity. The predictive value of such diabetes risk questionnaires is improved by adding information on family history of diabetes [10]. This improvement could be more striking in the non-obese.

Limitations of our study include its cross-sectional nature and the combination of a population-based study (KORA) with cohort studies specifically recruiting persons with a high risk for type 2 diabetes. In addition, the method of ascertainment of FHD was not identical in each centre.

The association of FHD with increased risk for prediabetes points towards an important role for FHD in the early pathogenesis of diabetes.